No profile data available.
Vycor Medical, Inc. (VYCO) is a healthcare company in the targeted healthcare equipment industry, based in Boca Raton, United States, with about 7 full-time employees.
It reported revenue of $1.86 million for fiscal year 2025, up 17.2% from fiscal year 2024, and net income of -$396,796. In Q2 2026 (the quarter ended June 30, 2026) revenue was $418,264, down 15.7% from a year before. UNITED STATES was its largest region in fiscal year 2025, with 100% of revenue. Its market capitalization was $2.24 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision.
Vycor Medical reported $1.86 million in revenue for fiscal year 2025, up 17.2% from $1.59 million in fiscal year 2024. In Q2 2026 revenue was $418,264.
UNITED STATES: 100% of revenue by region in fiscal year 2025, followed by Europe (under 1%).
$2.24 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Vasamed, Inc. (VSMD), Deltagen Inc. (DGEN), REMSleep Holdings, Inc. (RMSL), Beyond Air, Inc. (XAIR).